CombiGene invites analysts and shareholders to the company’s presentation at Aktiespararna’s digital event on October 19

On Monday 19 October at 10.30, CEO Jan Nilsson and Chief Research & Development Officer Karin Agerman will present at Aktiespararna’s digital event. CombiGene hereby invites analysts and shareholders to a comprehensive presentation of CombiGene’s latest advances in the epilepsy project CG01 and the fantastic opportunities that this project holds.
 
https://www.aktiespararna.se/aktiviteter/aktiedagen-digitalt-19-oktober-2020

Share